Danaher Corporation $DHR Shares Purchased by Machina Capital S.A.S.

Machina Capital S.A.S. boosted its holdings in Danaher Corporation (NYSE:DHR) by 25.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,802 shares of the conglomerate’s stock after acquiring an additional 5,910 shares during the quarter. Danaher comprises approximately 1.0% of Machina Capital S.A.S.’s portfolio, making the stock its 12th biggest holding. Machina Capital S.A.S.’s holdings in Danaher were worth $5,710,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Bank of Marin lifted its stake in shares of Danaher by 8.9% in the third quarter. Bank of Marin now owns 7,524 shares of the conglomerate’s stock valued at $1,492,000 after purchasing an additional 613 shares during the period. Envestnet Asset Management Inc. boosted its stake in shares of Danaher by 1.7% during the 3rd quarter. Envestnet Asset Management Inc. now owns 1,379,654 shares of the conglomerate’s stock worth $273,530,000 after acquiring an additional 23,690 shares in the last quarter. Telos Capital Management Inc. boosted its stake in shares of Danaher by 3.1% during the 3rd quarter. Telos Capital Management Inc. now owns 48,632 shares of the conglomerate’s stock worth $9,642,000 after acquiring an additional 1,472 shares in the last quarter. Ashton Thomas Private Wealth LLC grew its holdings in shares of Danaher by 5.3% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 5,553 shares of the conglomerate’s stock worth $1,103,000 after acquiring an additional 279 shares during the period. Finally, Premier Path Wealth Partners LLC increased its stake in Danaher by 18.5% in the 3rd quarter. Premier Path Wealth Partners LLC now owns 1,570 shares of the conglomerate’s stock valued at $311,000 after purchasing an additional 245 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the company. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Barclays increased their price objective on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Guggenheim lifted their target price on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 2nd. Robert W. Baird set a $251.00 price target on shares of Danaher in a report on Thursday, January 29th. Finally, Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 price objective (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $252.32.

Danaher Trading Down 3.0%

Shares of DHR opened at $216.65 on Wednesday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The company has a market capitalization of $153.03 billion, a PE ratio of 42.99, a price-to-earnings-growth ratio of 3.02 and a beta of 0.91. The stock has a fifty day moving average of $230.25 and a two-hundred day moving average of $214.64. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.14 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. As a group, analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 25.40%.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the transaction, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This trade represents a 66.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 30,248 shares of company stock worth $6,609,663 in the last three months. Company insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.